{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:07:00Z","timestamp":1791958020892,"version":"4.3.4"},"reference-count":30,"publisher":"BMJ","funder":[{"name":"National Institute for Health and Care Research (NIHR) developments and skills","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Boston Scientific","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,6,25]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>One-year mortality following acute myocardial infarction (AMI) has declined over time, yet the reasons for this improvement remain unclear. Understanding the drivers of these changes is essential for informing clinical strategies and health policy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analysed 852 914 adult patients admitted with AMI across England and Wales between 2005 and 2019 using national registry data. We examined changes in 1-year all-cause mortality and quantified the contribution of clinical, treatment and demographic factors to this trend using decomposition analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Between 2005 and 2019, 1-year all-cause mortality declined from 22.8% (95% CI 22.4% to 23.2%) to 14.2% (95% CI 13.7% to 14.7%), an absolute reduction of 8.6 percentage points. Approximately 68.2% of this decline was explained by measured factors. The greatest contributor was increased use of evidence-based pharmacological therapies\u2014including statins, beta blockers and ACE inhibitors\u2014accounting for 27.7% of the reduction (95% CI 26.0% to 29.5%). Increased use of percutaneous coronary intervention (PCI) contributed 17.6% (95% CI 16.3% to 19.0%). Mortality improvements were observed in both ST-elevation myocardial infarction (STEMI) and non-STEMI populations. However, older adults and women continued to experience higher mortality rates throughout the study period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>One-year survival after AMI improved substantially over 15 years in England and Wales largely due to advances in pharmacotherapy and PCI. Nevertheless, about one-third of the mortality decline remains unexplained, underscoring the need to investigate other contributors such as postdischarge care and health system factors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2024-325474","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:20:17Z","timestamp":1753118417000},"page":"heartjnl-2024-325474","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7527-9670","authenticated-orcid":false,"given":"Sharon A","family":"Ayayo","sequence":"first","affiliation":[{"name":"Division of Informatics, Imaging and Data Sciences, The University of Manchester Faculty of Biology, Medicine and Health, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3410-9472","authenticated-orcid":false,"given":"Glen Philip","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Informatics, Imaging and Data Sciences, The University of Manchester Faculty of Biology, Medicine and Health, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7978-1094","authenticated-orcid":false,"given":"Salwa","family":"Zghebi","sequence":"additional","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care, The University of Manchester Faculty of Biology, Medicine and Health, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-098X","authenticated-orcid":false,"given":"Vicky P","family":"Taxiarchi","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, Centre for Women\u2019s Mental Health, The University of Manchester Faculty of Biology, Medicine and Health, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9725-1583","authenticated-orcid":false,"given":"Muhammad","family":"Rashid","sequence":"additional","affiliation":[{"name":"Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-5815","authenticated-orcid":false,"given":"Evangelos","family":"Kontopantelis","sequence":"additional","affiliation":[{"name":"Division of Informatics, Imaging and Data Sciences, The University of Manchester Faculty of Biology, Medicine and Health, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-8890","authenticated-orcid":false,"given":"Mamas A","family":"Mamas","sequence":"additional","affiliation":[{"name":"Keele Cardiovascular Research Group, Keele University, Stoke on Trent, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"2025092006593243000_heartjnl-2024-325474v1.1","unstructured":"Mechanic OJ , Shamai A , Grossman MG . Acute Myocardial Infarction.2023. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459269\/"},{"key":"2025092006593243000_heartjnl-2024-325474v1.2","doi-asserted-by":"publisher","DOI":"10.1177\/2048872613502283"},{"key":"2025092006593243000_heartjnl-2024-325474v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.07.023"},{"key":"2025092006593243000_heartjnl-2024-325474v1.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab285"},{"key":"2025092006593243000_heartjnl-2024-325474v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.12.005"},{"key":"2025092006593243000_heartjnl-2024-325474v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx515"},{"key":"2025092006593243000_heartjnl-2024-325474v1.7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"The Lancet"},{"key":"2025092006593243000_heartjnl-2024-325474v1.8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20\u2008536 high-risk individuals: a randomised placebocontrolled trial","volume":"360","year":"2002","journal-title":"The Lancet"},{"key":"2025092006593243000_heartjnl-2024-325474v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.06.025"},{"key":"2025092006593243000_heartjnl-2024-325474v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2018.01.002"},{"key":"2025092006593243000_heartjnl-2024-325474v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132334"},{"key":"2025092006593243000_heartjnl-2024-325474v1.12","first-page":"115","article-title":"Multiple cardiovascular comorbidities and acute myocardial infarction: temporal trends (1990-2007) and impact on death rates at 30 days and 1 year","volume":"4","author":"McManus","year":"2012","journal-title":"Clin Epidemiol"},{"key":"2025092006593243000_heartjnl-2024-325474v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcw025"},{"key":"2025092006593243000_heartjnl-2024-325474v1.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.957803"},{"key":"2025092006593243000_heartjnl-2024-325474v1.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10766"},{"key":"2025092006593243000_heartjnl-2024-325474v1.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.522"},{"key":"2025092006593243000_heartjnl-2024-325474v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.192328"},{"key":"2025092006593243000_heartjnl-2024-325474v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx015"},{"key":"2025092006593243000_heartjnl-2024-325474v1.19","unstructured":"Office for National Statistics . Mortality statistics in England and Wales QMI, 2023. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/methodologies\/mortalitystatisticsinenglandandwalesqmi#quality-characteristics-of-the-mortality-data"},{"key":"2025092006593243000_heartjnl-2024-325474v1.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-016-0281-5","article-title":"Outcome-sensitive multiple imputation: a simulation study","volume":"17","author":"Kontopantelis","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"2025092006593243000_heartjnl-2024-325474v1.21","doi-asserted-by":"publisher","DOI":"10.1177\/09622802241244608"},{"key":"2025092006593243000_heartjnl-2024-325474v1.22","doi-asserted-by":"publisher","DOI":"10.3233\/JEM-2005-0259"},{"key":"2025092006593243000_heartjnl-2024-325474v1.23","unstructured":"Stata Statistical Software: Release 18. College Station, TX: StataCorp LLC, 2023."},{"key":"2025092006593243000_heartjnl-2024-325474v1.24","unstructured":"Jann B . FAIRLIE: Stata Module to Generate Nonlinear Decomposition of Binary Outcome Differentials.2006. Available: https:\/\/ideas.repec.org\/c\/boc\/bocode\/s456727.html"},{"key":"2025092006593243000_heartjnl-2024-325474v1.25","unstructured":"R: A Language and Environment for Statistical Computing, 2022. Available: https:\/\/www.R-project.org"},{"key":"2025092006593243000_heartjnl-2024-325474v1.26","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.a2018.0057"},{"key":"2025092006593243000_heartjnl-2024-325474v1.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070237","article-title":"Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registry","volume":"13","author":"Krishnamurthy","year":"2023","journal-title":"BMJ Open"},{"key":"2025092006593243000_heartjnl-2024-325474v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.01.021"},{"key":"2025092006593243000_heartjnl-2024-325474v1.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.115.002312"},{"key":"2025092006593243000_heartjnl-2024-325474v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780081211"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2024-325474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T13:59:42Z","timestamp":1758376782000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2024-325474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":30,"alternative-id":["10.1136\/heartjnl-2024-325474"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2024-325474","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}